Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr₹1,915 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹3,999 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr
Mar2020₹1,915 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr
7.16
Mar2020 ₹1,915 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹23,617.9 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses